Spread the news

The United States had agreed to buy 600,000 more doses of the therapy, sotrovimab, for an undisclosed sum. — Reuters pic
The United States had agreed to buy 600,000 more doses of the therapy, sotrovimab, for an undisclosed sum. — Reuters pic

Follow us on Instagram and subscribe to our Telegram channel for the latest updates.


NEW YORK, Jan 13 — GSK and Vir Biotechnology said today they are seeking US approval for their antibody-based Covid-19 treatment to be given as a shot in the arm, on top of the currently approved intravenous administration.

Yesterday, the drugmakers said the United States had agreed to buy 600,000 more doses of the therapy, sotrovimab, for an undisclosed sum, as the country bolsters its arsenal of treatments against the Omicron coronavirus variant. — Reuters


Spread the news
Advertisement

MELODYBIZ 50% DISCOUNT


Have you always desired a smooth online shopping experience. Do you have dreams of putting your goods out on platforms where you can get customers all over Nigeria. Then MelodyBiz Store is the right place for you. We offer competitive prices on goods and services and you can be rest assured to get what you ordered in the stipulated time. Log-on to MelodyBiz and experience a different dynamics of shopping
Previous articleMore US medical teams to bolster states as Omicron surges
Next articleSudan Goalie Abdallah: Super Eagles Don’t Scare Us

LEAVE A REPLY

Please enter your comment!
Please enter your name here